Mitochondrial CYP2D6 may be a powerful target for the treatment of Parkinson's disease induced by MPTP.
A new study reports mice infected with a flu virus had an increased risk of developing Parkinson's symptoms. Importantly, mice vaccinated against the flu were less sensitive to MPTP and less likely to develop Parkinson's like symptoms.
A drug usually used for the treatment of multiple sclerosis appears to increase the activity of Nrf2, a protein that protects the body from oxidative stress and inflammation associated with Parkinson's disease.
A new study reports chronic lack of sleep and irregular sleep wake patterns may worsen motor and learning deficits bought on by Parkinson's disease.
With a new insight into a model of Parkinson’s disease, researchers have identified a novel target for mitigating some of the disease’s toll on the brain.
